Almanack Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,411
| Closed | -$2.53M | – | 189 |
|
|
2024
Q2 | $2.53M | Sell |
2,411
-2,996
| -55% | -$3.15M | 0.43% | 42 |
|
|
2024
Q1 | $5.2M | Buy |
5,407
+2,807
| +108% | +$2.7M | 0.89% | 27 |
|
|
2023
Q4 | $2.28M | Sell |
2,600
-3,800
| -59% | -$3.34M | 0.42% | 38 |
|
|
2023
Q3 | $5.27M | Sell |
6,400
-800
| -11% | -$658K | 1.02% | 18 |
|
|
2023
Q2 | $5.17M | Buy |
7,200
+2,200
| +44% | +$1.58M | 0.91% | 19 |
|
|
2023
Q1 | $4.11M | Sell |
5,000
-6,300
| -56% | -$5.18M | 0.81% | 21 |
|
|
2022
Q4 | $8.15M | Buy |
+11,300
| New | +$8.15M | 1.74% | 11 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 161 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 67 |
|